Urology Market Report Suite - China - 2020-2026 - MedSuite
発行: iData Research Inc.
ページ情報: 英文 392 Pages
Throughout this medical market research, iData Research analyzed 49 urology companies in China and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this MedSuite report contains all of the Chinese Urological Device market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes a urological procedure volume analysis which can also be purchased as a separate report, MedPro.
1. Procedure Volumes for Urological Devices in China - MedPro
2. Urinary Incontinence Market - MedCore
3. Pelvic Organ Prolapse Repair Market - MedCore
4. Stone Management Market - MedCore
5. Benign Prostatic Hyperplasia (BPH) Treatment Market - MedCore
6. Erectile Dysfunction Market - MedCore
Chinese Urology Market Insights
The stable growth across the market is driven by an increasing number of procedures performed, fueled by the growing geriatric population and the incidence rates of associated diseases, including urinary incontinence, pelvic organ prolapse, urolithiasis, nephrolithiasis and prostatic diseases.
The pelvic organ prolapse repair market was the only declining portion of the total urological device market. The segment is expected to begin to recover over the forecast period, primarily driven by the growth in the sacrocolpopexy mesh segment.
Overall, the urological device market in China was valued at nearly $540 million in 2019. This is expected to increase over the forecast period at a CAGR of 1.7% to reach $605 million.